Mesenchymal stem cells, also known as mesenchymal stromal cells (MSCs), exist in many
tissues and are known to actively migrate to sites of tissue injury, where they participate in …

Infusion of different hematopoietic stem cell populations and ex vivo expanded endothelial
progenitor cells augments neovascularization of tissue after ischemia and contributes to …

We recently demonstrated that marrow stromal cells (MSCs) augment collateral remodeling
through release of several cytokines such as VEGF and bFGF rather than via cell …

Mesenchymal stem cells or multipotent stromal cells (MSCs) have initially captured attention
in the scientific world because of their differentiation potential into osteoblasts …

The discovery that mesenchymal stem cells (MSCs) are recruited into tumors has led to a
great deal of interest over the past decade in the function of MSCs in tumors. To address …

Background—Pluripotent mesenchymal stem cells (MSCs) differentiate into a variety of cells,
including cardiomyocytes and vascular endothelial cells. However, little information is …

Over the last decade, there has been a growing interest in the role of mesenchymal stem
cells (MSC) in cancer progression. These cells have the potential to give rise to a variety of …

Mesenchymal stem cells (MSCs) are pluripotent cells that differentiate into a variety of cells,
including cardiomyocytes and endothelial cells. However, little information is available …

Mesenchymal stem cells (MSCs), which potentially transdifferentiate into multiple cell types,
are increasingly reported to be beneficial in models of organ system injury. However, the …

Bone marrow (BM)-derived mesenchymal stem cells (MSCs) represent a promising
population for supporting new concepts in cellular therapy. This study was undertaken to …